This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mehta, J. Articles by Cohn, J. N. Search for Related Content PubMed PubMed Citation Articles by Mehta, J. Articles by Cohn, J. N.

Circulation, Vol 55, 370-375, Copyright © 1977 by American Heart Association

ARTICLES

Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects

J Mehta and JN Cohn

Labetalol was administered to six hypertensive subjects in increasing doses for seven days. A decrease in both supine and standing arterial pressure and heart rate was observed with no change in cardiac output and few side effects. Exercise tolerance was unaltered by the drug, but the heart rate and arterial pressure response to exercise were significantly blunted. The infusion rate of isoproterenol required to produce tachycardia was increased sevenfold by 800 mg/day labetalol and tenfold by 1600 mg/day. More than twice the control dose of phenylephrine was required during labetalol therapy to produce a rise in diastolic arterial pressure reflex tachycardia to amyl nitrite- induced hypotension was attenuated. These studies indingina pectoris.

This article has been cited by other articles:

				J. L. Mehta and L. M. Lopez Rebound Hypertension Following Abrupt Cessation of Clonidine and Metoprolol: Treatment With Labetalol Arch Intern Med, February 1, 1987; 147(2): 389 - 390. [Abstract] [PDF]

				E. L. MICHELSON and W. H. FRISHMAN Labetalol: An Alpha- and Beta-Adrenoceptor Blocking Drug Ann Intern Med, October 1, 1983; 99(4): 553 - 555. [Abstract] [PDF]

				J. D. Wallin and W. M. O'Neill Jr Labetalol: Current Research and Therapeutic Status Arch Intern Med, March 1, 1983; 143(3): 485 - 490. [Abstract] [PDF]

				D. L. Murray, S. M. Podos, C.-p. Wei, and I. H. Leopold Ocular Effects in Normal Rabbits of Topically Applied Labetalol: A Combined {alpha}- and {beta}-Adrenergic Antagonist Arch Ophthalmol, April 1, 1979; 97(4): 723 - 726. [Abstract] [PDF]

				J. Mehta Adrenergic Blockade in Hypertension JAMA, October 13, 1978; 240(16): 1759 - 1760. [Abstract] [PDF]